Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma.

Tamai K, Nakamura M, Mizuma M, Mochizuki M, Yokoyama M, Endo H, Yamaguchi K, Nakagawa T, Shiina M, Unno M, Muramoto K, Sato I, Satoh K, Sugamura K, Tanaka N.

Cancer Sci. 2014 Jun;105(6):667-74. doi: 10.1111/cas.12406. Epub 2014 May 8.

2.

Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.

Wang M, Xiao J, Shen M, Yahong Y, Tian R, Zhu F, Jiang J, Du Z, Hu J, Liu W, Qin R.

Int J Cancer. 2011 Jan 1;128(1):72-81. doi: 10.1002/ijc.25317.

3.

Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.

Lu D, Han C, Wu T.

Gastroenterology. 2011 Jun;140(7):2084-94. doi: 10.1053/j.gastro.2011.02.056. Epub 2011 Feb 24.

4.

Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.

Shen DY, Zhan YH, Wang QM, Rui G, Zhang ZM.

Liver Int. 2013 Jan;33(1):137-48. doi: 10.1111/liv.12014. Epub 2012 Nov 1.

PMID:
23121546
5.

Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.

Gao Q, Zhao YJ, Wang XY, Guo WJ, Gao S, Wei L, Shi JY, Shi GM, Wang ZC, Zhang YN, Shi YH, Ding J, Ding ZB, Ke AW, Dai Z, Wu FZ, Wang H, Qiu ZP, Chen ZA, Zhang ZF, Qiu SJ, Zhou J, He XH, Fan J.

Gastroenterology. 2014 May;146(5):1397-407. doi: 10.1053/j.gastro.2014.01.062. Epub 2014 Feb 4.

PMID:
24503127
6.

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.

Obchoei S, Weakley SM, Wongkham S, Wongkham C, Sawanyawisuth K, Yao Q, Chen C.

Mol Cancer. 2011 Aug 26;10:102. doi: 10.1186/1476-4598-10-102.

7.

Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.

Yao L, Han C, Song K, Zhang J, Lim K, Wu T.

Cancer Res. 2015 Apr 1;75(7):1388-98. doi: 10.1158/0008-5472.CAN-14-2561. Epub 2015 Feb 17.

8.

CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.

Wang M, Xiao J, Jiang J, Qin R.

Int J Cancer. 2011 Apr 15;128(8):1996-7. doi: 10.1002/ijc.25519. No abstract available.

9.

Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

Buranrat B, Prawan A, Kukongviriyapan U, Kongpetch S, Kukongviriyapan V.

World J Gastroenterol. 2010 May 21;16(19):2362-70.

10.

Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system.

Shima K, Mizuma M, Hayashi H, Nakagawa K, Okada T, Sakata N, Omura N, Kitamura Y, Motoi F, Rikiyama T, Katayose Y, Egawa S, Ishii N, Horii A, Unno M.

J Exp Clin Cancer Res. 2012 Jun 6;31:55. doi: 10.1186/1756-9966-31-55.

11.

MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.

Huang Q, Liu L, Liu CH, You H, Shao F, Xie F, Lin XS, Hu SY, Zhang CH.

Asian Pac J Cancer Prev. 2013;14(2):829-34.

12.

Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.

Nagai K, Ishii H, Miyoshi N, Hoshino H, Saito T, Sato T, Tomimaru Y, Kobayashi S, Nagano H, Sekimoto M, Doki Y, Mori M.

Biochem Biophys Res Commun. 2010 Apr 30;395(2):258-63. doi: 10.1016/j.bbrc.2010.03.176. Epub 2010 Apr 7.

PMID:
20381452
13.

Comment on: isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.

Gradilone A, Gazzaniga P, Raimondi C, Aglianò AM, Frati L.

Int J Cancer. 2011 Apr 15;128(8):1997-8. doi: 10.1002/ijc.25520. No abstract available.

14.
15.

Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Shimizu T, Yokomuro S, Mizuguchi Y, Kawahigashi Y, Arima Y, Taniai N, Mamada Y, Yoshida H, Akimaru K, Tajiri T.

World J Gastroenterol. 2006 Oct 21;12(39):6316-24.

16.

Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma.

Kokuryo T, Senga T, Yokoyama Y, Nagino M, Nimura Y, Hamaguchi M.

Cancer Res. 2007 Oct 15;67(20):9637-42.

17.

Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Meng F, Yamagiwa Y, Ueno Y, Patel T.

J Hepatol. 2006 Jun;44(6):1055-65. Epub 2005 Dec 13.

18.

Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.

Sang H, Li T, Li H, Liu J.

PLoS One. 2013 Nov 28;8(11):e81347. doi: 10.1371/journal.pone.0081347. eCollection 2013.

19.

Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment.

Yu Y, Liao M, Liu R, Chen J, Feng H, Fu Z.

World J Surg Oncol. 2014 Mar 31;12:78. doi: 10.1186/1477-7819-12-78.

20.

miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.

Lu L, Byrnes K, Han C, Wang Y, Wu T.

Mol Cancer Res. 2014 Jun;12(6):890-900. doi: 10.1158/1541-7786.MCR-13-0419. Epub 2014 Apr 3.

Supplemental Content

Support Center